A comprehensive strategy to address shortage of Erwinia asparaginase in pediatric acute lymphoblastic leukemia.
Anshul VagrechaVincent TaoRosemarie CorlessCassandra ColonArlene RednerMark AtlasPublished in: Expert review of clinical pharmacology (2023)
PEG desensitization is a safe, cost effective, and practical alternative in children with ALL and a Grade 2 or higher HSR.